Plasma angiopoietin-2 in clinical acute lung injury: prognostic and pathogenetic significance.
about
Biomarkers in Pediatric ARDS: Future DirectionsPediatric Acute Respiratory Distress Syndrome: Fluid Management in the PICUA Pathophysiologic Approach to Biomarkers in Acute Respiratory Distress SyndromeTreating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola.Plasma soluble thrombomodulin levels are associated with mortality in the acute respiratory distress syndrome.Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials.A high angiopoietin-2/angiopoietin-1 ratio is associated with a high risk of septic shock in patients with febrile neutropeniaSalvianolic acid B attenuates lipopolysaccharide-induced acute lung injury in rats through inhibition of apoptosis, oxidative stress and inflammation.Plasma angiopoietin-2 outperforms other markers of endothelial injury in prognosticating pediatric ARDS mortality.Resolution of pulmonary edema. Thirty years of progress.Performance of interleukin-27 as a sepsis diagnostic biomarker in critically ill adults.Proteomic profiles in acute respiratory distress syndrome differentiates survivors from non-survivors.Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.Estimating dead-space fraction for secondary analyses of acute respiratory distress syndrome clinical trialsDrug Repurposing Screen Identifies Foxo1-Dependent Angiopoietin-2 Regulation in Sepsis.Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies.Biomarkers of Endothelial Activation Are Associated with Poor Outcome in Critical Illness.Prognostic factors in the acute respiratory distress syndromePathophysiology of pulmonary hypertension in acute lung injury.Differences in degree, differences in kind: characterizing lung injury in traumaElevated soluble thrombomodulin is associated with organ failure and mortality in children with acute respiratory distress syndrome (ARDS): a prospective observational cohort study.The role of angiogenic factors and their soluble receptors in acute lung injury (ALI)/ acute respiratory distress syndrome (ARDS) associated with critical illnessLow Plasma Levels of Adiponectin Do Not Explain Acute Respiratory Distress Syndrome Risk: a Prospective Cohort Study of Patients with Severe Sepsis.Plasma Biomarker Analysis in Pediatric ARDS: Generating Future Framework from a Pilot Randomized Control Trial of Methylprednisolone: A Framework for Identifying Plasma Biomarkers Related to Clinical Outcomes in Pediatric ARDS.Ratio of angiopoietin-2 to angiopoietin-1 predicts mortality in acute lung injury induced by paraquatFixing the leak: targeting the vascular endothelium in sepsis.Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patientsNeutropenic sepsis is associated with distinct clinical and biological characteristics: a cohort study of severe sepsisRole of angiopoietin/tie2 in critical illness: promising biomarker, disease mediator, and therapeutic target?The temporal kinetics of circulating angiopoietin levels in children with sepsis.Inhibition of Murine Pulmonary Microvascular Endothelial Cell Apoptosis Promotes Recovery of Barrier Function under Septic Conditions.Biomarkers of endothelial activation/dysfunction in infectious diseases.Dysregulation of the angiopoietin-Tie-2 axis in sepsis and ARDS.Dynamics of pulmonary endothelial barrier function in acute inflammation: mechanisms and therapeutic perspectives.Biomarkers in acute respiratory distress syndrome: from pathobiology to improving patient care.Clinical and biological heterogeneity in acute respiratory distress syndrome: direct versus indirect lung injury.Acute respiratory distress syndrome on the intensive care unit.Biomarkers for the acute respiratory distress syndrome: how to make the diagnosis more precise.Serum biomarker analysis in patients with recurrent spontaneous abortion.The pulmonary endothelium in acute respiratory distress syndrome: insights and therapeutic opportunities.
P2860
Q26744577-64DCD718-2B40-40E6-A663-BD16A692EA39Q26751522-5FAB1067-F788-4D9F-AFA5-F24BC825A76CQ26765351-D7C9537F-5E36-4F00-BAEA-4A5A83E212C7Q28076034-18780403-E579-403E-B324-4B1057F3C42EQ30360456-A77446D9-C23F-4762-B945-F073F8A4E12AQ30826105-CB1EC211-1454-43D1-BBDE-22E6FF26EC26Q33752686-A2F379EA-ED4F-482A-B5F3-7FA95692F4FCQ33847444-54869381-7260-4588-8BD4-48EDD06B44B9Q33891477-BA8550E6-D13D-4ABE-8DA3-B97ACABE6E48Q33901613-79E82875-60EB-4F83-83D5-6E67BDCF665FQ34076339-22E4BA37-DF56-40A4-85F5-0D24BB364DE2Q34302302-312FFC19-D64D-473F-AADF-26A689FF4A0CQ34979725-08EAE31F-D476-4767-A12A-2039D1CDBD89Q35449898-2149C108-BBF5-498E-9DAE-3AB8CA965A01Q35597977-C4F65EA5-7A80-4644-9525-024BC977C42EQ35672843-DE666DD8-ED29-49C4-85F6-75960894C0AEQ35817214-0E89AE32-9EF9-4FDF-B088-0E2F26682937Q35946855-D9468381-83C2-4E10-9CF3-45077F7C9DACQ35994453-9B8E8636-AF68-4B4A-89BF-92E5A998CDE4Q36219321-42566D85-6D64-4660-8605-4B458B288642Q36424706-B57B5F5D-2440-41AE-96FC-E98CF47A32B6Q36616721-2174D576-2101-4A40-85C3-8A076C9E3EB8Q36694821-D13CF923-6FBA-4467-9688-D5C862E08D60Q36751000-4AB8B5B9-3AA7-43CE-9437-D9025EF70A8DQ36773889-2444FE42-88AA-4E73-BD36-40E9D35E7063Q36902680-6E3DF773-7BD4-4741-B09C-74F90E5D5DA0Q36917451-010EF570-EDC1-40C1-884D-C4644A95DBCAQ37108504-24AADCCB-90F2-4981-B35C-08F045141E03Q37288661-ADB89AAB-FACB-40E3-8751-9B545C337940Q37626268-A8AE7CE4-619D-4448-8219-B7FE7AF96D6EQ37637820-4F4B497F-2262-4ADD-A7C8-AF061FDB0679Q37713182-5C7B9977-209D-4D2D-885E-506BC9186B85Q38105018-53F96DBF-CFC9-4A8F-B590-1E12CE0CAAFCQ38193705-E2984122-CBCC-4465-B62E-C032F710E308Q38215937-EDF7FD69-1F14-42A4-88EA-CCD4592125E1Q38277156-79764754-C10E-4B8A-A980-F81AD16C3416Q38285554-F4BF896A-727D-40EA-B241-A9B2664EF8ADQ38638963-B0D17263-C70D-4F43-8FE4-CB80723CD142Q38693339-85079B17-DDBA-48A1-B19A-742B4121BC38Q38770657-8F23BFB6-D2A4-4C8C-AD0C-68D122DA848E
P2860
Plasma angiopoietin-2 in clinical acute lung injury: prognostic and pathogenetic significance.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Plasma angiopoietin-2 in clini ...... and pathogenetic significance.
@ast
Plasma angiopoietin-2 in clini ...... and pathogenetic significance.
@en
Plasma angiopoietin-2 in clini ...... and pathogenetic significance.
@nl
type
label
Plasma angiopoietin-2 in clini ...... and pathogenetic significance.
@ast
Plasma angiopoietin-2 in clini ...... and pathogenetic significance.
@en
Plasma angiopoietin-2 in clini ...... and pathogenetic significance.
@nl
prefLabel
Plasma angiopoietin-2 in clini ...... and pathogenetic significance.
@ast
Plasma angiopoietin-2 in clini ...... and pathogenetic significance.
@en
Plasma angiopoietin-2 in clini ...... and pathogenetic significance.
@nl
P2093
P2860
P1476
Plasma angiopoietin-2 in clini ...... and pathogenetic significance.
@en
P2093
B Taylor Thompson
Diana Gallagher
Jason Abbott
NHLBI ARDS Network
P2860
P304
P356
10.1097/CCM.0B013E3182451C87
P407
P577
2012-06-01T00:00:00Z